Cadila Healthcare informs about press release

27 May 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated May 27, 2021 titled ‘Zydus seeks DCGI approval to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID infection’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

890.20 -6.40 (-0.71%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×